Document Detail

The Global Cell Therapy Industry Continues to Rise during the Second and Third Quarters of 2012.
MedLine Citation:
PMID:  23217418     Owner:  NLM     Status:  In-Data-Review    
During Q2-Q3 2012, the cell therapy industry benefited from a number of positive external influences including advantageous changes to future FDA regulation, but stock market activity was highly mixed. The FDA approved two more products and an appreciable number of public-company-sponsored clinical trials are progressing through phases 1-3.
Chris Mason; Mark J McCall; Emily J Culme-Seymour; Shalini Suthasan; Simon Edwards-Parton; Gregory A Bonfiglio; Brock C Reeve
Related Documents :
24489108 - Autonomy, best interests and the public interest: treatment, non-treatment and the valu...
2360218 - Synthesis of [11,11,12,12-2h4]progesterone for mass spectral investigations of peripher...
23117488 - Effect of the neutral clots 1 trial on the use of graduated compression stockings in th...
24786258 - A case of imported middle east respiratory syndrome coronavirus infection and public he...
11965378 - Benzimidazole-based fxa inhibitors with improved thrombin and trypsin selectivity.
22317698 - Work of gravediggers and health.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cell stem cell     Volume:  11     ISSN:  1875-9777     ISO Abbreviation:  Cell Stem Cell     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101311472     Medline TA:  Cell Stem Cell     Country:  United States    
Other Details:
Languages:  eng     Pagination:  735-9     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Inc. All rights reserved.
The Advanced Centre for Biochemical Engineering, University College London, Torrington Place, London, WC1E 6BT, UK. Electronic address:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Utf1: Goldilocks for ESC Bivalency.
Next Document:  Nuclear cloning and direct reprogramming: the long and the short path to Stockholm.